Human Metabolome Technologies, Inc. (6090.T)

JPY 672.0

(-0.44%)

Operating Expenses Summary of Human Metabolome Technologies, Inc.

  • Human Metabolome Technologies, Inc.'s latest annual operating expenses in 2023 was 639.4 Million JPY , up 0.06% from previous year.
  • Human Metabolome Technologies, Inc.'s latest quarterly operating expenses in 2023 FY was 649.16 Million JPY , up 0.06% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a annual operating expenses of 648.77 Million JPY in annual operating expenses 2022, down -0.01% from previous year.
  • Human Metabolome Technologies, Inc. reported a annual operating expenses of 648.85 Million JPY in annual operating expenses 2021, down -15.37% from previous year.
  • Human Metabolome Technologies, Inc. reported a quarterly operating expenses of 649.16 Million JPY for 2023 FY, up 0.06% from previous quarter.
  • Human Metabolome Technologies, Inc. reported a quarterly operating expenses of 152.86 Million JPY for 2023 Q1, down -13.77% from previous quarter.

Annual Operating Expenses Chart of Human Metabolome Technologies, Inc. (2023 - 2019)

Historical Annual Operating Expenses of Human Metabolome Technologies, Inc. (2023 - 2019)

Year Operating Expenses Operating Expenses Growth
2023 639.4 Million JPY 0.06%
2022 648.77 Million JPY -0.01%
2021 648.85 Million JPY -15.37%
2020 766.65 Million JPY -12.26%
2019 873.76 Million JPY 0.0%

Peer Operating Expenses Comparison of Human Metabolome Technologies, Inc.

Name Operating Expenses Operating Expenses Difference
Shin Nippon Biomedical Laboratories, Ltd. 9.85 Billion JPY 93.514%
DNA Chip Research Inc. 324.19 Million JPY -97.227%
Cosmo Bio Company,Limited 2.73 Billion JPY 76.587%
H.U. Group Holdings, Inc. 67.27 Billion JPY 99.05%
FALCO HOLDINGS Co., Ltd. 10.77 Billion JPY 94.064%
BML, Inc. 36.46 Billion JPY 98.246%
Precision System Science Co., Ltd. 1.9 Billion JPY 66.464%